Pharmafile Logo
Pharmafocus logo
Advanced Search

advanced breast cancer

Showing 4 posts of 4 posts found.

Kadcyla

NICE says no to NHS funding for Kadcyla

December 16, 2015
Research and Development, Sales and Marketing Breast Cancer Now, Kadcyla, NHS, NICE, Roche, advanced breast cancer, breast cancer

NICE has turned down Roche’s application for NHS funding for Kadcyla as a treatment for a type of advanced breast …

News
afinitor_logo

Blow for Scottish women as SMC rejects Afinitor for advanced breast cancer

October 12, 2015
Sales and Marketing SMC, advanced breast cancer

The Scottish Medicines Consortium (SMC) has announced that it will not recommend Novartis’s Afinitor (everolimus) for use in advanced breast …

News
Novartis Afinitor (everolimus)

Afinitor stops tumour growth in advanced breast cancer

July 5, 2011
Manufacturing and Production, Research and Development Afinitor, Novartis, Votubia, advanced breast cancer

Novartis’ Afinitor has impressed in a late-stage trial by increasing survival in women with advanced breast cancer. The phase III …

News

Eisai prepares ground for Halaven’s European launch

March 7, 2011
Sales and Marketing Cancer, EMBRACE, Eisai, Halaven, advanced breast cancer, breast cancer, eribulin

Eisai has published further details of a phase III trial of its first-in-class chemotherapy drug Halaven ahead of its hoped-for …

News

Latest content

FDA approves Amgen’s Imdelltra for extensive-stage small cell lung cancer

May 17, 2024

AstraZeneca shares results from phase 3 trial of COVID-19 prevention drug

May 17, 2024

GSK pledges £45m to Fleming Initiative to fight AMR

May 16, 2024

NeuroSense partners with PhaseV on upcoming phase 3 ALS trial

May 16, 2024

AstraZeneca adds new heart failure target through collaboration with BenevolentAI

May 15, 2024